During the past decade, Louisiana Hematology Oncology Associates LLC conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 21 clinical trials were completed, i.e. on average, 30.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 19 clinical trials were completed. i.e. 90.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana Hematology Oncology Associates LLC" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana Hematology Oncology Associates LLC" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana Hematology Oncology Associates LLC" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (5 trials), "Breast Carcinoma" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Louisiana Hematology Oncology Associates LLC" in a lesser frequency.

Most popular intervention types in "Louisiana Hematology Oncology Associates LLC" are "Drug" (61 trials), "Other" (57 trials), "Biological" (30 trials), "Procedure" (25 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (28 trials), "Laboratory Biomarker Analysis" (22 trials), "Questionnaire Administration" (19 trials), "Biospecimen Collection" (18 trials) and "Computed Tomography" (16 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Hematology Oncology Associates LLC" are 75 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Louisiana Hematology Oncology Associates LLC". undefined are not yet recruiting, 23 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Louisiana Hematology Oncology Associates LLC, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Hematology Oncology Associates LLC, 1 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".